Yelena Bykhovskaya, Anastasia Gromova, Helen P Makarenkova, Yaron S Rabinowitz
{"title":"Abnormal regulation of extracellular matrix and adhesion molecules in corneas of patients with keratoconus.","authors":"Yelena Bykhovskaya, Anastasia Gromova, Helen P Makarenkova, Yaron S Rabinowitz","doi":"10.5005/jp-journals-10025-1123","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To identify changes in the expression of genes coding for extracellular matrix (ECM) proteins in patients with non-inflammatory corneal disorder keratoconus (KC), patients with corneal scarring, and normal controls.</p><p><strong>Materials and methods: </strong>Total RNA extracted from corneal tissue of 13 KC patients, 2 patients with corneal scaring and 4 normal controls was analyzed using Human Extracellular Matrix & Adhesion Molecules Profiler PCR Array. Statistically significant changes in gene expression were identified using the Data Analysis software.</p><p><strong>Results: </strong>Comparison of KC and control corneas with thresholds of 1.5 or greater fold change and a p-value of 0.05 or lower, revealed 21 differentially expressed genes, 16 genes were downregulated and 5 were upregulated. Among transcripts downregulated in KC patients we identified THBS1, ADAMTS1, SPP1, several collagens and integrins. We found TGFBI (BIGH3) gene was the most significantly upregulated transcript.</p><p><strong>Conclusion: </strong>Development of keratoconus results in deregulation of gene expression of extracellular matrix and adhesion molecules.</p><p><strong>Clinical significance: </strong>Downregulation of collagens and upregulation of TGFBI repeatedly identified in KC patients may be used as clinical markers of the disease.</p>","PeriodicalId":92051,"journal":{"name":"International journal of keratoconus and ectatic corneal diseases","volume":"5 2","pages":"63-70"},"PeriodicalIF":0.0000,"publicationDate":"2016-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5005/jp-journals-10025-1123","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of keratoconus and ectatic corneal diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10025-1123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19
Abstract
Aim: To identify changes in the expression of genes coding for extracellular matrix (ECM) proteins in patients with non-inflammatory corneal disorder keratoconus (KC), patients with corneal scarring, and normal controls.
Materials and methods: Total RNA extracted from corneal tissue of 13 KC patients, 2 patients with corneal scaring and 4 normal controls was analyzed using Human Extracellular Matrix & Adhesion Molecules Profiler PCR Array. Statistically significant changes in gene expression were identified using the Data Analysis software.
Results: Comparison of KC and control corneas with thresholds of 1.5 or greater fold change and a p-value of 0.05 or lower, revealed 21 differentially expressed genes, 16 genes were downregulated and 5 were upregulated. Among transcripts downregulated in KC patients we identified THBS1, ADAMTS1, SPP1, several collagens and integrins. We found TGFBI (BIGH3) gene was the most significantly upregulated transcript.
Conclusion: Development of keratoconus results in deregulation of gene expression of extracellular matrix and adhesion molecules.
Clinical significance: Downregulation of collagens and upregulation of TGFBI repeatedly identified in KC patients may be used as clinical markers of the disease.